A newly described disease occurring in children and linked to COVID-19 has significant changes in white blood cellsa discovery that may allow doctors to better assess their young patients' condition and predict their resistance to current treatments, a new study reveals.

For our comprehensive coverage and latest updates on COVID-19 click here.

Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection (PIMS-TS) is a new disease which shares some features with Kawasaki disease, as well as toxic shock syndrome.

Experts examined blood samples from children admitted with the diseases to Birmingham Children's Hospital during the UK's coronavirus lockdowndiscovering that large changes in the monocytes (a type of white blood cell) in patients with PIMS-TS and Kawasaki's Disease.